3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
19
Glioma
12
Brain Neoplasms
8
Astrocytoma
7
Neoplasms
6
Neuroblastoma
5
Gliosarcoma
3
Diffuse Intrinsic Pontine Glioma
3
Spinal Cord Neoplasms
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Recurrence
2
Pancreatic Neoplasms
2
Oligodendroglioma
2
Melanoma
2
Medulloblastoma
2
Wilms Tumor
1
Rhabdoid Tumor
1
Refractory Solid Tumors
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasm Metastasis
1
Melanoma, Cutaneous Malignant
1
Lymphoma, Follicular
1
Hepatoblastoma
1
Ganglioneuroblastoma
1
Interventions
Carboplatin
12
atezolizumab
11
Etoposide
10
PM 01183
8
durvalumab
6
Topotecan
6
Specimen Handling
4
pembrolizumab
3
Magnetic Resonance Spectroscopy
3
AMG 757
3
Paclitaxel
2
Irinotecan
2
Injections
2
Drug Therapy
2
Cisplatin
2
Biopsy
2
trastuzumab deruxtecan
1
toripalimab
1
olaparib
1
lenvatinib
1
futibatinib
1
fludarabine
1
enzalutamide
1
cabozantinib
1
berzosertib
1
avelumab
1
arginine decarboxylase
1
amrubicin
1
Vaccines
1
Taxes
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
Temozolomide
×
30 days
×
Clear all
No trials found.